Unternehmen Intelligent Medicine Acquisition Corp. Nasdaq
Aktien
A3C69Y
US45828D2053
IQMDU
Holdinggesellschaften
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Gregory Simon
CEO | Chief Executive Officer | 72 | 04.11.21 |
Geoffrey S. Ling
PRN | Corporate Officer/Principal | - | - |
Sue Siegel
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | - | |
Jonathan Fleming
PRN | Corporate Officer/Principal | 66 | - |
Peter Knight
PRN | Corporate Officer/Principal | 73 | - |
Corporate Officer/Principal | 79 | - | |
Samir Khleif
PRN | Corporate Officer/Principal | 60 | - |
Llew Keltner
PRN | Corporate Officer/Principal | 74 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 77 | 04.11.21 | |
Jack Hidary
CHM | Chairman | 55 | 04.11.21 |
Gregory Simon
CEO | Chief Executive Officer | 72 | 04.11.21 |
Kavita Patel
BRD | Director/Board Member | 50 | 04.11.21 |
Director/Board Member | - | 04.11.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 5 175 000 | 5 175 000 ( 100,00 %) | 0 | 28,00 % |
Aktie B | 1 | 20 700 000 | 2 070 000 ( 10,00 %) | 0 |
Unternehmenskontakt
Intelligent Medicine Acquisition Corp.
9001 Burdette Road
20817, Bethesda
+
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+190,94 % | 7,13 Mrd. | |
+2,14 % | 982 Mio. | |
+41,91 % | 872 Mio. | |
+26,98 % | 820 Mio. | |
+1,72 % | 664 Mio. | |
+5,92 % | 648 Mio. | |
-.--% | 600 Mio. | |
+3,61 % | 503 Mio. | |
-.--% | 500 Mio. |